Completed
Companies know exactly what they spend on research, but knowing exactly what they get for their money is a persistent problem. Without a good way to measure value, research—especially innovative fundamental research—can be viewed as a cost that can be cut to boost near-term earnings (supposedly without long-term consequences). The number of patents is one metric for measuring the value of research, but that information is not necessarily useful without knowing the business value of those patents in the marketplace. What other metrics serve to highlight the value of research and innovation?
Featured publication
Workshop_in_brief
·2017
Companies know exactly what they spend on research, but knowing exactly what they get for their money is a more difficult question to answer. Without a good way to measure value, research can be viewed as a cost that can be cut to boost near-term earnings. The number of patents is one metric for mea...
View details
Description
An ad hoc committee will organize a public workshop on assessing the value and impact of research investments, looking at measures other than the counting of patents. The focus of the workshop, which will be held in conjunction with the June 2017 GUIRR meeting, will be on corporate research investments, primarily, but touch upon federal research investment assessment and trends as well. A brief rapporteur-authored proceedings will be published.
Collaborators
Staff
Susan Sauer Sloan
Lead
Megan Nicholson
Major units and sub-units
National Academy of Sciences
Collaborator
National Academy of Medicine
Collaborator
Policy and Global Affairs
Lead
Government-University-Industry-Philanthropy Research Roundtable
Lead
U.S. Science and Innovation Policy
Lead